Archived News
In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally
invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.
VISIT NEW SITEEN1 signs another five programmatic partnerships: expects further revenue rises
1 minute read
engage:BDR (ASX:EN1 and EN1O) has signed five more large scale programmatic partnerships.
All of these partnerships, which include include kiip, Advangelists, PulsePoint and RhythmOne, are expected to be strong revenue contributors for the EN1 programmatic exchange and all five integrations are now live and in test phases
EN1 recently announced a 50% increase in revenues to $17.1 million and an operating profit of $1.6 million, assisted by a strong improvement in gross margins which were up from 38% in the previous corresponding period to 54%.
Management’s expectation of significant revenue contribution is based on the unique, non-overlapping demand and ad opportunities relative to the EN1’s current business.
AdCel onboards Criteo
Additionally, AdCel has on-boarded Criteo, one of the largest global programmatic buyers.
This brings the number of new programmatic integrations made by EN1 in the March quarter to seven, exceeding the target of 5 for the quarter, and bringing the total programmatic integrations to 225.
With regard to new publishers, EN1 is on-boarding a new large-scale app publisher MocoSpace, the largest mobile gaming community in North America.
MocoSpace has been a popular platform since the peak of MySpace.
As MocoSpace is new to the EN1 programmatic exchange, management will update shareholders soon with regards to new NetZero publisher on-boarding activity.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
Publishers Notice
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain.